Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/5656C2D2A91F3B4717F10BD99730F97215AB04F917B5E6E32F3B9EDF01636F9A20A57B5AE0456BAB0253F8B9AC8B454Ahttp://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/5656C2D2A91F3B4717F10BD99730F97215AB04F917B5E6E32F3B9EDF01636F9A20A57B5AE0456BAB0253F8B9AC8B454Ahttp://www.w3.org/2000/01/rdf-schema#comment"Especially in tumor cells accumulating studies have revealed the molecular mechanisms of DYRK2 from the aspect of apoptosis proliferation EMT and stem- ness. Considering in vitro and xenograft studies as well as down-regulation of DYRK2 in tumor specimens DYRK2 is an important candidate for tumor suppressor. (review)"xsd:string
http://purl.uniprot.org/uniprot/#_79FFCC614315247A50BCEE43F729B20E2F3941DB97F307A52B074E69C5CB3C23BAB6A31C759CAA2A8EB30D780887AD0Ehttp://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/5656C2D2A91F3B4717F10BD99730F97215AB04F917B5E6E32F3B9EDF01636F9A20A57B5AE0456BAB0253F8B9AC8B454A
http://purl.uniprot.org/uniprot/Q92630http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/5656C2D2A91F3B4717F10BD99730F97215AB04F917B5E6E32F3B9EDF01636F9A20A57B5AE0456BAB0253F8B9AC8B454A
http://purl.uniprot.org/uniprot/#_Q92630-mappedCitation-31505048http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/5656C2D2A91F3B4717F10BD99730F97215AB04F917B5E6E32F3B9EDF01636F9A20A57B5AE0456BAB0253F8B9AC8B454A